{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:11Z","timestamp":1791859271706,"version":"4.3.4"},"reference-count":147,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1681\/asn.2014080837","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T01:44:41Z","timestamp":1427247881000},"page":"1489-1502","source":"Crossref","is-referenced-by-count":177,"title":["Utility of HLA Antibody Testing in Kidney Transplantation"],"prefix":"10.1681","volume":"26","author":[{"given":"Ana","family":"Konvalinka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Tinckam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20230208","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation.","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"R2-7-20230208","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(75)92010-3","article-title":"Lymphocyte-dependent antibody and renal graft rejection.","volume":"1","author":"Stiller","year":"1975","journal-title":"Lancet"},{"key":"R3-7-20230208","first-page":"764","article-title":"Flow cytometry crossmatching in human cadaver kidney transplantation.","volume":"19","author":"Iwaki","year":"1987","journal-title":"Transplant Proc"},{"key":"R4-7-20230208","first-page":"409","article-title":"The flow cytometry crossmatch in kidney transplantation.","volume":"1987","author":"Cook","year":"1987","journal-title":"Clin Transpl"},{"key":"R5-7-20230208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007890-199003000-00011","article-title":"The flow cytometric crossmatch and early renal transplant loss.","volume":"49","author":"Mahoney","year":"1990","journal-title":"Transplantation"},{"key":"R6-7-20230208","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00007890-199001000-00011","article-title":"Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.","volume":"49","author":"Kerman","year":"1990","journal-title":"Transplantation"},{"key":"R7-7-20230208","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00007890-199308000-00007","article-title":"The significance of a positive flow cytometry crossmatch test in primary kidney transplantation.","volume":"56","author":"Ogura","year":"1993","journal-title":"Transplantation"},{"key":"R8-7-20230208","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1681\/ASN.V12122807","article-title":"Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.","volume":"12","author":"Karpinski","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R9-7-20230208","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00007890-199812270-00043","article-title":"Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.","volume":"66","author":"Bryan","year":"1998","journal-title":"Transplantation"},{"key":"R10-7-20230208","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/00007890-200004150-00027","article-title":"Sensitization and sensitivity: Defining the unsensitized patient.","volume":"69","author":"Gebel","year":"2000","journal-title":"Transplantation"},{"key":"R11-7-20230208","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection.","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-7-20230208","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"R13-7-20230208","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1034\/j.1399-0012.2000.140505.x","article-title":"Detection of alloantibodies against non-HLA antigens in kidney transplantation by flow cytometry.","volume":"14","author":"Rodr\u00edguez","year":"2000","journal-title":"Clin Transplant"},{"key":"R14-7-20230208","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2010.437","article-title":"De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection.","volume":"79","author":"Sun","year":"2011","journal-title":"Kidney Int"},{"key":"R15-7-20230208","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-197604000-00006","article-title":"Importance of the autocontrol crossmatch in human renal transplantation.","volume":"21","author":"Cross","year":"1976","journal-title":"Transplantation"},{"key":"R16-7-20230208","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0140-6736(77)90544-X","article-title":"Renal transplantation and B-cell cross-matches with autoantibodies and alloantibodies.","volume":"2","author":"Ting","year":"1977","journal-title":"Lancet"},{"key":"R17-7-20230208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00007890-198305000-00007","article-title":"Cadaver renal transplant outcome in recipients with autolymphocytotoxic antibodies.","volume":"35","author":"Ettenger","year":"1983","journal-title":"Transplantation"},{"key":"R18-7-20230208","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00007890-198912000-00011","article-title":"Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.","volume":"48","author":"Taylor","year":"1989","journal-title":"Transplantation"},{"key":"R19-7-20230208","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00007890-198906000-00008","article-title":"Contributions and clinical significance of IgM and autoantibodies in highly sensitized renal allograft recipients.","volume":"47","author":"Vaidya","year":"1989","journal-title":"Transplantation"},{"key":"R20-7-20230208","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1399-0012.2001.00005.x","article-title":"IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.","volume":"15","author":"Bryan","year":"2001","journal-title":"Clin Transplant"},{"key":"R21-7-20230208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.TP.0000047311.77702.59","article-title":"Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.","volume":"75","author":"Le Bas-Bernardet","year":"2003","journal-title":"Transplantation"},{"key":"R22-7-20230208","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/j.1600-6143.2007.01944.x","article-title":"Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches.","volume":"7","author":"Patel","year":"2007","journal-title":"Am J Transplant"},{"key":"R23-7-20230208","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2007.01667.x","article-title":"Pretransplant risk assessment in renal allograft recipients using virtual crossmatching.","volume":"7","author":"Bielmann","year":"2007","journal-title":"Am J Transplant"},{"key":"R24-7-20230208","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.humimm.2009.05.001","article-title":"Back to the future: Application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.","volume":"70","author":"Taylor","year":"2009","journal-title":"Hum Immunol"},{"key":"R25-7-20230208","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.trre.2009.01.001","article-title":"Histocompatibility methods.","volume":"23","author":"Tinckam","year":"2009","journal-title":"Transplant Rev (Orlando"},{"key":"R26-7-20230208","first-page":"87","article-title":"Solid phase HLA antibody detection technology\u2014challenges in interpretation.","volume":"76","author":"Tait","year":"2010","journal-title":"Tissue Antigens"},{"key":"R27-7-20230208","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12026-009-8154-1","article-title":"Immunogenetics and immunology in transplantation.","volume":"47","author":"Zachary","year":"2010","journal-title":"Immunol Res"},{"key":"R28-7-20230208","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1432-2277.2012.01491.x","article-title":"Detection and clinical relevance of donor specific HLA antibodies: A matter of debate.","volume":"25","author":"Roelen","year":"2012","journal-title":"Transpl Int"},{"key":"R29-7-20230208","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-61779-842-9_17","article-title":"HLA antibody detection and characterization by solid phase immunoassays: Methods and pitfalls.","volume":"882","author":"Zachary","year":"2012","journal-title":"Methods Mol Biol"},{"key":"R30-7-20230208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-62703-493-7_6","article-title":"Transplantation of the sensitized patient: Histocompatibility testing.","volume":"1034","author":"Montgomery","year":"2013","journal-title":"Methods Mol Biol"},{"key":"R31-7-20230208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOT.0b013e3283636ddf","article-title":"Current role of human leukocyte antigen matching in kidney transplantation.","volume":"18","author":"S\u00fcsal","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"R32-7-20230208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bmb\/ldu005","article-title":"Detection of donor-specific antibodies in kidney transplantation.","volume":"110","author":"Haarberg","year":"2014","journal-title":"Br Med Bull"},{"key":"R33-7-20230208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/IR:29:1-3:041","article-title":"Evolution of HLA antibody detection: Technology emulating biology.","volume":"29","author":"Bray","year":"2004","journal-title":"Immunol Res"},{"key":"R34-7-20230208","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA antibody-mediated rejection workshop.","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant"},{"key":"R35-7-20230208","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"R36-7-20230208","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0198-8859(00)00253-6","article-title":"Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: II. Clinical relevance.","volume":"62","author":"Zachary","year":"2001","journal-title":"Hum Immunol"},{"key":"R37-7-20230208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007890-200301150-00008","article-title":"Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.","volume":"75","author":"Pei","year":"2003","journal-title":"Transplantation"},{"key":"R38-7-20230208","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0198-8859(98)00020-2","article-title":"Simultaneous HLA Class I and Class II antibodies screening with flow cytometry.","volume":"59","author":"Pei","year":"1998","journal-title":"Hum Immunol"},{"key":"R39-7-20230208","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0198-8859(99)00121-4","article-title":"Flow cytometric detection of HLA antibodies using a spectrum of microbeads.","volume":"60","author":"Pei","year":"1999","journal-title":"Hum Immunol"},{"key":"R40-7-20230208","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00007890-198503000-00024","article-title":"Calculation of a predictive value for transplantation.","volume":"39","author":"Zachary","year":"1985","journal-title":"Transplantation"},{"key":"R43-7-20230208","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: Initial results show benefits for sensitized patients and a reduction in positive crossmatches.","volume":"11","author":"Cecka","year":"2011","journal-title":"Am J Transplant"},{"key":"R44-7-20230208","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): The new measure of sensitization for transplant candidates.","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"R45-7-20230208","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1600-6143.2006.01521.x","article-title":"Transplanting the highly sensitized patient: The emory algorithm.","volume":"6","author":"Bray","year":"2006","journal-title":"Am J Transplant"},{"key":"R46-7-20230208","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/TP.0b013e3181c926f2","article-title":"Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation.","volume":"89","author":"Taylor","year":"2010","journal-title":"Transplantation"},{"key":"R47-7-20230208","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival.","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"R48-7-20230208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/TP.0000000000000203","article-title":"Determinants of C1q binding in the single antigen bead assay.","volume":"98","author":"Schaub","year":"2014","journal-title":"Transplantation"},{"key":"R50-7-20230208","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"R51-7-20230208","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads\u2014a technical solution for the prozone effect.","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"key":"R52-7-20230208","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1744-313X.2012.01147.x","article-title":"The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera.","volume":"40","author":"Weinstock","year":"2013","journal-title":"Int J Immunogenet"},{"key":"R53-7-20230208","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/TP.0b013e318199c581","article-title":"Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.","volume":"87","author":"Kosmoliaptsis","year":"2009","journal-title":"Transplantation"},{"key":"R54-7-20230208","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.1000424","article-title":"Antibodies to HLA-E in nonalloimmunized males: Pattern of HLA-Ia reactivity of anti-HLA-E-positive sera.","volume":"185","author":"Ravindranath","year":"2010","journal-title":"J Immunol"},{"key":"R55-7-20230208","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.molimm.2009.10.024","article-title":"HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: Relevance to human natural HLA antibodies.","volume":"47","author":"Ravindranath","year":"2010","journal-title":"Mol Immunol"},{"key":"R56-7-20230208","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2009.04.001","article-title":"Naturally occurring interference in Luminex assays for HLA-specific antibodies: Characteristics and resolution.","volume":"70","author":"Zachary","year":"2009","journal-title":"Hum Immunol"},{"key":"R57-7-20230208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.humimm.2009.11.003","article-title":"Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantation.","volume":"71","author":"Masson","year":"2010","journal-title":"Hum Immunol"},{"key":"R58-7-20230208","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.tp.0000269615.91036.52","article-title":"The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.","volume":"84","author":"Gloor","year":"2007","journal-title":"Transplantation"},{"key":"R59-7-20230208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humimm.2013.08.083","article-title":"8-P: Pretreatment of patient serum with fetal bovine serum (FBS) reduces non-specific background and enhances HLA antibody detection in bead and cell based assays.","volume":"74","author":"Breitenbach","year":"2013","journal-title":"Hum Immunol"},{"key":"R60-7-20230208","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/TP.0b013e3181ac6198","article-title":"Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.","volume":"88","author":"Cai","year":"2009","journal-title":"Transplantation"},{"key":"R61-7-20230208","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.humimm.2011.02.012","article-title":"Donor-specific antibody against denatured HLA-A1: Clinically nonsignificant?","volume":"72","author":"Pereira","year":"2011","journal-title":"Hum Immunol"},{"key":"R62-7-20230208","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/ajt.12332","article-title":"Influence of test technique on sensitization status of patients on the kidney transplant waiting list.","volume":"13","author":"Gombos","year":"2013","journal-title":"Am J Transplant"},{"key":"R63-7-20230208","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males.","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"R64-7-20230208","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.humimm.2009.06.020","article-title":"Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood.","volume":"70","author":"El-Awar","year":"2009","journal-title":"Hum Immunol"},{"key":"R65-7-20230208","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.humimm.2011.08.001","article-title":"Heart transplantation with donor-specific antibodies directed toward denatured HLA-A*02:01: A case report.","volume":"72","author":"Poli","year":"2011","journal-title":"Hum Immunol"},{"key":"R66-7-20230208","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/trf.12064","article-title":"Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay.","volume":"53","author":"Gandhi","year":"2013","journal-title":"Transfusion"},{"key":"R67-7-20230208","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/TP.0b013e31829c2481","article-title":"On the detection of anti-HLA antibodies using single antigen bead Luminex assay: Lot-to-lot variations in MFI.","volume":"96","author":"Friedlander","year":"2013","journal-title":"Transplantation"},{"key":"R68-7-20230208","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1600-6135.2003.00273.x","article-title":"Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk.","volume":"3","author":"Gebel","year":"2003","journal-title":"Am J Transplant"},{"key":"R69-7-20230208","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00007890-199912270-00007","article-title":"Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.","volume":"68","author":"Kerman","year":"1999","journal-title":"Transplantation"},{"key":"R70-7-20230208","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/j.1600-6143.2010.03191.x","article-title":"Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.","volume":"10","author":"Lonze","year":"2010","journal-title":"Am J Transplant"},{"key":"R71-7-20230208","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome.","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R72-7-20230208","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival.","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R73-7-20230208","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/TP.0b013e3181856f98","article-title":"Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.","volume":"86","author":"Reinsmoen","year":"2008","journal-title":"Transplantation"},{"key":"R74-7-20230208","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation.","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"R75-7-20230208","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab.","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"R76-7-20230208","first-page":"393","article-title":"Desensitization protocol using bortezomib for highly sensitized patients awaiting heart or lung transplants.","volume":"2009","author":"Weston","year":"2009","journal-title":"Clin Transpl"},{"key":"R77-7-20230208","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humimm.2005.01.032","article-title":"Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.","volume":"66","author":"Zachary","year":"2005","journal-title":"Hum Immunol"},{"key":"R78-7-20230208","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial.","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R79-7-20230208","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch.","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant"},{"key":"R80-7-20230208","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation.","volume":"10","author":"Gloor","year":"2010","journal-title":"Am J Transplant"},{"key":"R81-7-20230208","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0b013e31822dc38d","article-title":"Human leukocyte antigen antibody-incompatible renal transplantation: Excellent medium-term outcomes with negative cytotoxic crossmatch.","volume":"92","author":"Higgins","year":"2011","journal-title":"Transplantation"},{"key":"R82-7-20230208","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ndt\/gfr429","article-title":"Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.","volume":"27","author":"Caro-Oleas","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R83-7-20230208","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R84-7-20230208","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"R85-7-20230208","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R86-7-20230208","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trim.2013.07.002","article-title":"Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter?","volume":"29","author":"Crespo","year":"2013","journal-title":"Transpl Immunol"},{"key":"R87-7-20230208","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/TP.0b013e3181dc13e7","article-title":"C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection.","volume":"89","author":"H\u00f6nger","year":"2010","journal-title":"Transplantation"},{"key":"R88-7-20230208","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant"},{"key":"R89-7-20230208","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1432-2277.2010.01166.x","article-title":"Significance of qualitative and quantitative evaluations of anti-HLA antibodies in kidney transplantation.","volume":"24","author":"Ishida","year":"2011","journal-title":"Transpl Int"},{"key":"R90-7-20230208","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0b013e3181a5e034","article-title":"Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.","volume":"87","author":"Amico","year":"2009","journal-title":"Transplantation"},{"key":"R91-7-20230208","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/TP.0b013e3181e36e08","article-title":"Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation.","volume":"90","author":"Riethm\u00fcller","year":"2010","journal-title":"Transplantation"},{"key":"R92-7-20230208","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/ndt\/gfl202","article-title":"Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification.","volume":"21","author":"Gibney","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R93-7-20230208","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1600-6143.2008.02387.x","article-title":"Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss.","volume":"8","author":"Eng","year":"2008","journal-title":"Am J Transplant"},{"key":"R94-7-20230208","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure.","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant"},{"key":"R95-7-20230208","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/TP.0b013e3181f6a07b","article-title":"Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes.","volume":"90","author":"Singh","year":"2010","journal-title":"Transplantation"},{"key":"R96-7-20230208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajt.12512","article-title":"Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology.","volume":"14","author":"Sicard","year":"2014","journal-title":"Am J Transplant"},{"key":"R97-7-20230208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/TP.0b013e31820794bb","article-title":"Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay.","volume":"91","author":"Couzi","year":"2011","journal-title":"Transplantation"},{"key":"R98-7-20230208","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.humimm.2009.04.011","article-title":"Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.","volume":"70","author":"Aubert","year":"2009","journal-title":"Hum Immunol"},{"key":"R99-7-20230208","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.humimm.2009.04.018","article-title":"Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.","volume":"70","author":"Vlad","year":"2009","journal-title":"Hum Immunol"},{"key":"R100-7-20230208","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e3182100f77","article-title":"No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: A Collaborative Transplant Study report.","volume":"91","author":"S\u00fcsal","year":"2011","journal-title":"Transplantation"},{"key":"R101-7-20230208","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: A multicenter study.","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"R102-7-20230208","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00007890-197606000-00007","article-title":"Recipient selection for renal retransplantation.","volume":"21","author":"Opelz","year":"1976","journal-title":"Transplantation"},{"key":"R103-7-20230208","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"key":"R104-7-20230208","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000129260.86766.67","article-title":"The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: Short waiting time and excellent graft outcome.","volume":"78","author":"Claas","year":"2004","journal-title":"Transplantation"},{"key":"R105-7-20230208","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(06)69115-0","article-title":"Domino paired kidney donation: A strategy to make best use of live non-directed donation.","volume":"368","author":"Montgomery","year":"2006","journal-title":"Lancet"},{"key":"R106-7-20230208","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.294.13.1655","article-title":"Clinical results from transplanting incompatible live kidney donor\/recipient pairs using kidney paired donation.","volume":"294","author":"Montgomery","year":"2005","journal-title":"JAMA"},{"key":"R107-7-20230208","first-page":"626","article-title":"Single-center kidney paired donation: The Methodist San Antonio experience.","volume":"7","author":"Bingaman","year":"2012","journal-title":"Am J Transplant"},{"key":"R108-7-20230208","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/TP.0b013e318181fe3b","article-title":"Ingredients for a successful living donor kidney exchange program.","volume":"86","author":"de Klerk","year":"2008","journal-title":"Transplantation"},{"key":"R109-7-20230208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: A prospective trial.","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"R110-7-20230208","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.tp.0000174338.97313.5a","article-title":"Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial.","volume":"80","author":"Terasaki","year":"2005","journal-title":"Transplantation"},{"key":"R111-7-20230208","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.TP.0000055833.65192.3B","article-title":"Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.","volume":"75","author":"Worthington","year":"2003","journal-title":"Transplantation"},{"key":"R112-7-20230208","first-page":"323","article-title":"Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: Results of sixteen-year monitoring by flow cytometry.","volume":"2006","author":"Piazza","year":"2006","journal-title":"Clin Transpl"},{"key":"R113-7-20230208","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/TP.0b013e3182126ed0","article-title":"Natural history of proteinuria in renal transplant recipients developing de novo human leukocyte antigen antibodies.","volume":"91","author":"Fotheringham","year":"2011","journal-title":"Transplantation"},{"key":"R114-7-20230208","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"R115-7-20230208","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies.","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"key":"R116-7-20230208","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R117-7-20230208","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss.","volume":"16","author":"Sutherland","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R118-7-20230208","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1111\/j.1600-6143.2012.04251.x","article-title":"Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.","volume":"12","author":"Ginevri","year":"2012","journal-title":"Am J Transplant"},{"key":"R119-7-20230208","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation.","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"R120-7-20230208","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/TP.0b013e3182139da1","article-title":"Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes.","volume":"91","author":"Cooper","year":"2011","journal-title":"Transplantation"},{"key":"R121-7-20230208","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure.","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"R122-7-20230208","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1600-6143.2007.01855.x","article-title":"Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction.","volume":"7","author":"Scornik","year":"2007","journal-title":"Am J Transplant"},{"key":"R123-7-20230208","first-page":"171","article-title":"Donor-specific HLA antibodies in chronic renal allograft rejection: A prospective trial with a four-year follow-up.","volume":"2006","author":"Lachmann","year":"2006","journal-title":"Clin Transpl"},{"key":"R124-7-20230208","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R125-7-20230208","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant"},{"key":"R126-7-20230208","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.2012.190","article-title":"Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.","volume":"82","author":"DeVos","year":"2012","journal-title":"Kidney Int"},{"key":"R127-7-20230208","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1432-2277.2005.00085.x","article-title":"Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.","volume":"18","author":"Cardarelli","year":"2005","journal-title":"Transpl Int"},{"key":"R128-7-20230208","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure.","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"key":"R129-7-20230208","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1600-6143.2006.01503.x","article-title":"Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure.","volume":"6","author":"Campos","year":"2006","journal-title":"Am J Transplant"},{"key":"R130-7-20230208","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/TP.0b013e3181b11b72","article-title":"HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.","volume":"88","author":"Lee","year":"2009","journal-title":"Transplantation"},{"key":"R131-7-20230208","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1432-2277.2008.00755.x","article-title":"Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.","volume":"21","author":"Li","year":"2008","journal-title":"Transpl Int"},{"key":"R132-7-20230208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0b013e31829434d4","article-title":"Early versus late acute antibody-mediated rejection in renal transplant recipients.","volume":"96","author":"D\u00f6rje","year":"2013","journal-title":"Transplantation"},{"key":"R133-7-20230208","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/TP.0b013e3181cbac02","article-title":"Beyond histology: Lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection.","volume":"89","author":"Everly","year":"2010","journal-title":"Transplantation"},{"key":"R134-7-20230208","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318218e901","article-title":"Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.","volume":"91","author":"Walsh","year":"2011","journal-title":"Transplantation"},{"key":"R135-7-20230208","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-6143.2009.02577.x","article-title":"Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.","volume":"9","author":"Everly","year":"2009","journal-title":"Am J Transplant"},{"key":"R136-7-20230208","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1600-6143.2009.02591.x","article-title":"Comparison of combination Plasmapheresis\/IVIg\/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.","volume":"9","author":"Lefaucheur","year":"2009","journal-title":"Am J Transplant"},{"key":"R137-7-20230208","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/TP.0b013e3182543950","article-title":"De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.","volume":"94","author":"Willicombe","year":"2012","journal-title":"Transplantation"},{"key":"R138-7-20230208","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/TP.0b013e31816f612a","article-title":"Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.","volume":"85","author":"Amico","year":"2008","journal-title":"Transplantation"},{"key":"R139-7-20230208","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-6143.2006.01644.x","article-title":"Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival.","volume":"7","author":"Terasaki","year":"2007","journal-title":"Am J Transplant"},{"key":"R140-7-20230208","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/TP.0b013e31824fd8f1","article-title":"Posttransplant major histocompatibility complex class I chain-related gene A antibodies and long-term graft outcomes in a multicenter cohort of 779 kidney transplant recipients.","volume":"93","author":"Lemy","year":"2012","journal-title":"Transplantation"},{"key":"R141-7-20230208","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"R142-7-20230208","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"R143-7-20230208","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/TP.0b013e3181fdd9b0","article-title":"The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation.","volume":"90","author":"Flechner","year":"2010","journal-title":"Transplantation"},{"key":"R144-7-20230208","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MOT.0b013e3283626149","article-title":"Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.","volume":"18","author":"Wiebe","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"R145-7-20230208","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"R146-7-20230208","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"R147-7-20230208","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1600-6143.2011.03604.x","article-title":"De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.","volume":"11","author":"Katerinis","year":"2011","journal-title":"Am J Transplant"},{"key":"R148-7-20230208","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1600-6143.2009.02764.x","article-title":"Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"R149-7-20230208","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJM199409223311202","article-title":"Equitable allocation of HLA-compatible kidneys for local pools and minorities.","volume":"331","author":"Takemoto","year":"1994","journal-title":"N Engl J Med"},{"key":"R150-7-20230208","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00007890-199807150-00006","article-title":"Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function.","volume":"66","author":"McKenna","year":"1998","journal-title":"Transplantation"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201507000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:27:05Z","timestamp":1786130825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201507000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":147,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014080837","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}